Apellis abandons ALS drug after study miss
BioPharma
Stay updated with breaking news from Wave Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Wave Life Sciences Ltd. (NASDAQ:WVE – Get Rating) have been given an average recommendation of “Moderate Buy” by the six research firms that are covering the stock, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average […]
RA Capital's latest quarterly 13F fund update showcases new positions in the multistage healthcare and life science-focused fund.
Potent and durable target engagement observed across cohorts, including with 10 mg doses administered every 12 weeks which were also generally safe and well-tolerated WVE-004 did not show clinical... | May 23, 2023